| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6813303 | Psychiatry Research | 2016 | 5 Pages |
Abstract
Patients were showing more than 20% increase in prolactin levels had a better chance of responding to risperidone therapy. Taq1A DRD2 gene did not show any association with prolactin elevation and response to risperidone.
Keywords
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Alladi Charan, Deepak Gopal Shewade, Ravi Philip Rajkumar, Adithan Chandrasekaran,